Skip to main content
Toggle navigation
Login
Search
Home
Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Toufigh Gordi, PhD
Executive Director of Clinical Pharmacology
Rigel Pharmaceuticals
Poster(s):
(T-046) A Mixed-effect Pharmacokinetic Model of R835, a Novel Dual IRAK1/4, in Healthy Volunteers After Administration of the Prodrug R289
Tuesday, November 12, 2024
7:00 AM – 5:00 PM
MST
